Published in Mol Cell Biochem on February 21, 1989
La autoantigen enhances and corrects aberrant translation of poliovirus RNA in reticulocyte lysate. J Virol (1993) 5.89
A nuclear localization signal binding protein in the nucleolus. J Cell Biol (1990) 1.78
Mosquito homolog of the La autoantigen binds to Sindbis virus RNA. J Virol (1996) 1.71
Nucleocytoplasmic shuttling of the progesterone receptor. EMBO J (1991) 1.69
Epstein-Barr virus noncoding RNAs are confined to the nucleus, whereas their partner, the human La protein, undergoes nucleocytoplasmic shuttling. J Cell Biol (2006) 1.35
A subset of hY RNAs is associated with erythrocyte Ro ribonucleoproteins. EMBO J (1990) 1.34
Intracellular redistribution of truncated La protein produced by poliovirus 3Cpro-mediated cleavage. J Virol (1999) 1.33
La autoantigen enhances translation of BiP mRNA. Nucleic Acids Res (2001) 1.33
Bidirectional transport of glucocorticoid receptors across the nuclear envelope. Proc Natl Acad Sci U S A (1993) 1.13
Characterization of the autoantigen La (SS-B) as a dsRNA unwinding enzyme. Nucleic Acids Res (1997) 1.04
The La antigen inhibits the activation of the interferon-inducible protein kinase PKR by sequestering and unwinding double-stranded RNA. Nucleic Acids Res (1994) 1.01
Developmental characterization of a Drosophila RNA-binding protein homologous to the human systemic lupus erythematosus-associated La/SS-B autoantigen. Mol Cell Biol (1994) 1.01
All small nuclear RNAs (snRNAs) of the [U4/U6.U5] Tri-snRNP localize to nucleoli; Identification of the nucleolar localization element of U6 snRNA. Mol Biol Cell (2002) 0.92
Genetic analysis of a La homolog in Drosophila melanogaster. Nucleic Acids Res (2000) 0.90
Characterization of murine monoclonal antibodies against 60-kD Ro/SS-A and La/SS-B autoantigens. Clin Exp Immunol (1995) 0.87
Epstein-Barr Virus-Encoded RNAs: Key Molecules in Viral Pathogenesis. Cancers (Basel) (2014) 0.81
The human autoantigen La/SS-B accelerates herpes simplex virus type 1 replication in transfected mouse 3T3 cells. Clin Exp Immunol (1998) 0.79
A La autoantigen homologue is required for the internal ribosome entry site mediated translation of giardiavirus. PLoS One (2011) 0.79
Novel RNA chaperone domain of RNA-binding protein La is regulated by AKT phosphorylation. Nucleic Acids Res (2014) 0.78
Rpe65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle. Nat Genet (1998) 7.57
Yeast HAP1 activator binds to two upstream activation sites of different sequence. Cell (1987) 4.37
Yeast HAP1 activator competes with the factor RC2 for binding to the upstream activation site UAS1 of the CYC1 gene. Cell (1987) 3.46
Amino acid sequence requirements in the epitope recognized by the alpha-tubulin-specific rat monoclonal antibody YL 1/2. EMBO J (1984) 2.32
Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data. Addiction (2003) 2.06
A transcriptional insulator at the imprinted H19/Igf2 locus. Genes Dev (2000) 1.88
Imprinting of mouse Kvlqt1 is developmentally regulated. Hum Mol Genet (1998) 1.86
Targeted disruption of the Kcnq1 gene produces a mouse model of Jervell and Lange-Nielsen Syndrome. Proc Natl Acad Sci U S A (2001) 1.76
Inhibition of replication of the etiologic agent of acquired immune deficiency syndrome (human T-lymphotropic retrovirus/lymphadenopathy-associated virus) by avarol and avarone. J Natl Cancer Inst (1987) 1.73
H19 and Igf2 monoallelic expression is regulated in two distinct ways by a shared cis acting regulatory region upstream of H19. Genes Dev (2000) 1.70
Four new bioactive manzamine-type alkaloids from the Philippine marine sponge Xestospongia ashmorica. J Nat Prod (1996) 1.70
Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice. Neurobiol Aging (2008) 1.59
The location of drug binding sites in human serum albumin. Biochem Pharmacol (1981) 1.48
Regulatory mechanisms at the mouse Igf2/H19 locus. Mol Cell Biol (2001) 1.41
Virazole (1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide; a cytostatic agent. Biochem Pharmacol (1977) 1.40
Inhibition of herpesvirus DNA synthesis by 9-beta-D-arabinofuranosyladenine in cellular and cell-free systems. Ann N Y Acad Sci (1977) 1.39
Action of bleomycin on DNA and RNA. Eur J Biochem (1972) 1.38
Characterization of the autoantigen La as a nucleic acid-dependent ATPase/dATPase with melting properties. Cell (1990) 1.36
Bacteria of the Genus Roseobacter Associated with the Toxic Dinoflagellate Prorocentrum lima. Protist (2009) 1.35
Organization of the regulatory region of the yeast CYC7 gene: multiple factors are involved in regulation. Mol Cell Biol (1987) 1.33
Neuromuscular control of walking with chronic low-back pain. Man Ther (2003) 1.31
Association of La and Ro antigens with intracellular structures in HEp-2 carcinoma cells. Proc Natl Acad Sci U S A (1986) 1.26
Hyperforin as a possible antidepressant component of hypericum extracts. Life Sci (1998) 1.25
gp120 of HIV-1 induces apoptosis in rat cortical cell cultures: prevention by memantine. Eur J Pharmacol (1992) 1.23
Interferon production in patients infected with HIV-1. J Infect Dis (1989) 1.23
Characterization of an important drug binding area on human serum albumin including the high-affinity binding sites of warfarin and azapropazone. Mol Pharmacol (1982) 1.22
Association of AUUUA-binding protein with A+U-rich mRNA during nucleo-cytoplasmic transport. J Mol Biol (1992) 1.21
Long-term genome stability and minimal genotypic and phenotypic alterations in HPV16 E7-, but not E6-, immortalized human uroepithelial cells. Genes Dev (1994) 1.20
Origin of insulin receptor-like tyrosine kinases in marine sponges. Biol Bull (1999) 1.18
Detection of human immunodeficiency virus-1 nucleic acid on inactivated filter paper disks by polymerase chain reaction and microtiter plate assay. Microbiol Immunol (1994) 1.17
Transport of mRNA from nucleus to cytoplasm. Prog Nucleic Acid Res Mol Biol (1987) 1.17
Inhibitors acting on nucleic acid synthesis in an oncogenic RNA virus. Nat New Biol (1971) 1.15
Upregulation of the 2-5A synthetase/RNase L antiviral pathway associated with chronic fatigue syndrome. Clin Infect Dis (1994) 1.14
Differential gene expression of IFN-alpha and tumor necrosis factor-alpha in peripheral blood mononuclear cells from patients with AIDS related complex and AIDS. J Immunol (1990) 1.14
Influences of nonspecific low back pain on three-dimensional lumbar spine kinematics in locomotion. Spine (Phila Pa 1976) (2001) 1.13
Anti-HIV-1 activity of inorganic polyphosphates. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 1.12
Potent inhibition of hepatitis B virus production in vitro by modified pyrimidine nucleosides. Antimicrob Agents Chemother (1990) 1.12
Cytoprotective effect of NMDA receptor antagonists on prion protein (PrionSc)-induced toxicity in rat cortical cell cultures. Eur J Pharmacol (1993) 1.12
The comparison of beta-thymosin homologues among metazoa supports an arthropod-nematode clade. J Mol Evol (2000) 1.11
Intracellular distribution of the La antigen in CV-1 cells after herpes simplex virus type 1 infection compared with the localization of U small nuclear ribonucleoprotein particles. J Gen Virol (1989) 1.11
Localization of Epstein-Barr virus-encoded RNAs EBER-1 and EBER-2 in interphase and mitotic Burkitt lymphoma cells. Proc Natl Acad Sci U S A (1992) 1.11
Effects of EGb 761 Ginkgo biloba extract on mitochondrial function and oxidative stress. Pharmacopsychiatry (2003) 1.11
Expression of silicatein and collagen genes in the marine sponge Suberites domuncula is controlled by silicate and myotrophin. Eur J Biochem (2000) 1.11
Identification of specific BRCA1 and BRCA2 variants by DHPLC. Hum Mutat (2000) 1.10
Mature mRNA is selectively released from the nuclear matrix by an ATP/dATP-dependent mechanism sensitive to topoisomerase inhibitors. J Biol Chem (1987) 1.08
Mammalian intestinal alkaline phosphatase acts as highly active exopolyphosphatase. Biochim Biophys Acta (2001) 1.08
Purification of brain tubulin-tyrosine ligase by biochemical and immunological methods. J Cell Biol (1985) 1.08
Primmorphs generated from dissociated cells of the sponge Suberites domuncula: a model system for studies of cell proliferation and cell death. Mech Ageing Dev (1998) 1.07
Phosphorylation of arabinofuranosylthymine in non-infected and herpesvirus (TK+ and TK-)-infected cells. J Gen Virol (1979) 1.06
Simple 2,4-diacylphloroglucinols as classic transient receptor potential-6 activators--identification of a novel pharmacophore. Mol Pharmacol (2009) 1.05
Inhibition of GABA and benzodiazepine receptor binding by penicillins. Neurosci Lett (1980) 1.04
Mode of action of 9-beta-D-arabinofuranosyladenine on the synthesis of DNA, RNA, and protein in vivo and in vitro. Cancer Res (1975) 1.04
ROS generation, lipid peroxidation and antioxidant enzyme activities in the aging brain. J Neural Transm (Vienna) (2001) 1.03
Inhibition of expression of human immunodeficiency virus-1 in vitro by antibody-targeted liposomes containing antisense RNA to the env region. J Biol Chem (1990) 1.03
Cellular and biochemical responses to environmental and experimentally induced stress in sea urchin coelomocytes. Cell Stress Chaperones (2000) 1.03
DNA-dependent DNA polymerase pattern in noninfected and herpesvirus infected rabbit kidney cells. Arch Gesamte Virusforsch (1973) 1.02
Identification of the Ro and La antigens in the endoribonuclease VII--ribonucleoprotein complex. Biochem J (1987) 1.02
Flavonoids and the aging brain. J Physiol Pharmacol (2005) 1.01
Application of cell culture for the production of bioactive compounds from sponges: synthesis of avarol by primmorphs from Dysidea avara. J Nat Prod (2000) 1.01
Human serum albumin as a 'silent receptor' for drugs and endogenous substances. Pharmacology (1979) 1.01
Characterization of a common binding site for basic drugs on human alpha 1-acid glycoprotein (orosomucoid). Naunyn Schmiedebergs Arch Pharmacol (1983) 1.00
Effect of cordycepin on nucleic acid metabolism in L5178Y cells and on nucleic acid-synthesizing enzyme systems. Cancer Res (1977) 1.00
Inhibition of intrinsic protein tyrosine kinase activity of EGF-receptor kinase complex from human breast cancer cells by the marine sponge metabolite (+)-aeroplysinin-1. Comp Biochem Physiol B (1990) 1.00
The D-mannose-specific lectin from Gerardia savaglia blocks binding of human immunodeficiency virus type I to H9 cells and human lymphocytes in vitro. J Acquir Immune Defic Syndr (1988) 0.99
Purification and characterization of a species-specific aggregation factor in sponges. Exp Cell Res (1973) 0.99
Change of processing and nucleocytoplasmic transport of mRNA in HSV-1-infected cells. Virus Res (1989) 0.99
Potent antileukemic activity of the novel cytostatic agent avarone and its analogues in vitro and in vivo. Cancer Res (1985) 0.99
Shuttling of the autoantigen La between nucleus and cell surface after uv irradiation of human keratinocytes. Exp Cell Res (1990) 0.99
Early evolution of metazoan serine/threonine and tyrosine kinases: identification of selected kinases in marine sponges. Mol Biol Evol (1997) 0.98
Protection of HeLa-T4+ cells against human immunodeficiency virus (HIV) infection after stable transfection with HIV LTR-2',5'-oligoadenylate synthetase hybrid gene. FASEB J (1990) 0.98
Cathepsin, a major protease of the marine sponge Geodia cydonium: purification of the enzyme and molecular cloning of cDNA. Mol Mar Biol Biotechnol (1997) 0.97
Sarcophytolide: a new neuroprotective compound from the soft coral Sarcophyton glaucum. Toxicology (1998) 0.97
Production of the cytostatic agent aeroplysinin by the sponge Verongia aerophoba in in vitro culture. Comp Biochem Physiol C (1992) 0.96
Studies on protein kinases involved in regulation of nucleocytoplasmic mRNA transport. Biochem J (1988) 0.96
Bleomycin, an antibiotic that removes thymine from double-stranded DNA. Prog Nucleic Acid Res Mol Biol (1977) 0.95
Occurrence of novel small RNAs with concomitant inhibition of host cellular U small nuclear RNA synthesis in Vero cells infected with herpes simplex virus type 1. J Gen Virol (1986) 0.95